2 Layers

Our purpose

To improve life during and beyond sedation

Sedana Medical is a pioneer medtech and pharmaceutical company dedicated to making inhaled sedation a standard therapy in intensive care.

More about us

Bringing inhaled sedation to intensive care

We are proud to introduce inhaled sedation to intensive care, a paradigm shift in the care of critically ill patients.

Through the results obtained in the pivotal study with Sedaconda (isoflurane) and Sedaconda ACD*, we have laid the foundation for inhaled sedation in intensive care.

By this, we have also taken a major step closer to our vision – to make inhaled sedation a standard therapy in intensive care.

*formerly known as AnaConDa

Learn more

Sedana Sedaconda Hand 02 (2)

Science & Clinical Research

We pave the way for a paradigm shift in sedation in intensive care through knowledge sharing and clinical research.

Sedasource is an online resource for healthcare professionals, providing scientific and clinical material on the sedation of critically ill patients.  

Our research aims at a greater understanding of and increased knowledge about inhaled sedation, leading to medical advances for the benefit of patients in intensive care.

We also believe in working in partnerships – through various initiatives and research projects – that can lead to continued development and meaningful improvement for both patients and the healthcare system.

Learn More

Press Releases

Sedana Medical receives US patent for Sedaconda ACD-S


Sedana Medical AB (publ) announces that the US Patent and Trademark Office (USPTO) has granted Sedan…

Sedana Medical’s CEO and CFO acquire shares in the company


Sedana Medical AB’s (publ) CEO Johannes Doll and CFO Johan Spetz have each acquired 100,000 shares i…

View All Press Releases

Our products

Explore our broad portfolio of products for the administration of inhaled anaesthetics.

Learn More

View All Products